Peptide Therapy Workflow
Prescribe Peptides. Chart Them Defensibly.
Compounded peptides are cash-pay, off-label, and watched by state boards. The clinics that win will be the ones whose charts hold up. Record the consult. Get a note that documents medical necessity, consent, and the monitoring plan. Build titration and repeat labs into the care plan. Let every follow-up justify the renewal.
Defensible By Default
The Chart a State Board Wants to See
A peptide prescription without a chart behind it is what gets clinics in trouble. Meelio listens to the visit and writes the note in your format, with the elements a reviewer looks for: the indication, why an approved alternative is not suitable, the consent conversation, the monitoring plan, and the pharmacy it went to.
Not a template pasted in. What was actually said in the room, structured the way scrutiny reads it.
Indication and necessity
Diagnosis, why an FDA-approved alternative is not suitable, rationale for this peptide
Written informed consent
Compounded and off-label status, known and unknown risks, monitoring expectations
Baseline and monitoring labs
IGF-1, fasting glucose, HbA1c, lipids reviewed; repeat at 12 weeks
Pharmacy source
Named 503A pharmacy, licensed in the patient's state
Titration and stop point
Dose response recorded against a defined stop point
Written from the visit · Your format · Sent to your EMR
One Consult, Fully Charted
The Peptide Consult, Step by Step
A peptide service line is protocol-driven, lab-gated, and titrated over months. Every step already has a place in Meelio's workflow.
Before
Pre-consult prep
Intake, history, and prior labs summarized before you walk in. Cancer history, pregnancy status, and current medications surfaced, not buried.
Before
Baseline labs
IGF-1, fasting glucose, HbA1c, lipids, CBC, and CMP read in your order and flagged against your ranges, the way you would read them.
During
The consult
Record the visit. The note documents the indication, medical necessity, and the consent conversation in your format, in about 2 minutes.
After
The care plan
Titration schedule, reconstitution and injection instructions, side effects to report, repeat labs at set intervals, and a defined stop point. Your protocols, your dosing.
After
Follow-ups
Each visit compared to the last: response, labs that moved, continued justification for renewal. A renewal is a re-evaluation, not a rubber stamp.
Between
Nothing slips
Dose adjustments and patient questions between visits become pending actions on the chart, so the paper trail stays complete.
What Meelio Does Not Do
Meelio does not decide what you can prescribe. Which peptides a 503A pharmacy can compound changes as FDA rules move, and the clinical decision is always yours. We keep a peptide compounding status page as a reference, and your pharmacy has the final word.
Frequently Asked Questions
No. What a 503A pharmacy can compound changes as FDA rules move, and the prescribing decision is always yours. We maintain a peptide compounding status page that tracks where commonly prescribed peptides stand, but it is reference material, not legal or medical advice. Confirm current status with your compounding pharmacy before writing.
Built for Privacy. Designed
for Compliance.
Meelio is built to meet the highest data protection standards in the US, UK, and EU.
Record Your Consultation. Get Your Note in 2 Minutes. Ask Your Practice Anything.
Send it to your EMR. Go home on time.
